Nattokinase and blood pressure, what the newer meta-analyses actually show

Posted by tiredmira in Research & News - 3 points, 0 comments.

Been digging into nattokinase research again this week because my own BP numbers have been creeping up and I wanted to see what the current evidence actually says.

The newer fibrinolytic enzyme meta-analyses I have looked at keep pointing in the same direction, modest systolic drops in people with mild hypertension, somewhere in the ballpark of a few mmHg, with the best effect in folks already on the higher end. For me that's basically the most interesting part. A small real change that compounds over years is kind of the whole game for cardiovascular stuff.

What I like is the mechanism. Fibrin degradation plus tPA upregulation plus PAI-1 suppression is a very different story from just "thins your blood a bit." And the half-life of around 8 to 12 hours makes a once or twice daily schedule actually make sense, which matters when you are trying to track HRV and recovery against it.

The thing that worries me is bleeding risk stacking. Anyone here running it alongside low-dose aspirin or omega-3s, and how are you monitoring? HRV alone doesn't really tell me if something is off, so I'm curious what people actually use as a safety signal.

Community discussion - research and educational context only. Not medical advice.